Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
10.80
-0.56 (-4.93%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Elicio Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Net Income
-39.57-51.9-35.2-28.21-26.4
Upgrade
Depreciation & Amortization
1.131.181.171.060.25
Upgrade
Loss (Gain) From Sale of Assets
--00.110-
Upgrade
Stock-Based Compensation
2.71.451.180.580.62
Upgrade
Other Operating Activities
2.248.240.14.540.72
Upgrade
Change in Accounts Payable
-0.37-3.330.021.130.03
Upgrade
Change in Other Net Operating Assets
-3.087.29-0.08-1.280.84
Upgrade
Operating Cash Flow
-36.95-37.07-32.69-22.18-23.94
Upgrade
Capital Expenditures
-0.02-0.09-0.07-0.65-0.53
Upgrade
Sale of Property, Plant & Equipment
-00.03--
Upgrade
Investing Cash Flow
-0.02-0.08-0.03-0.65-0.53
Upgrade
Short-Term Debt Issued
-19.73--14.68
Upgrade
Long-Term Debt Issued
9.87-10--
Upgrade
Total Debt Issued
9.8719.7310-14.68
Upgrade
Net Debt Issued (Repaid)
9.8719.7310-14.68
Upgrade
Issuance of Common Stock
26.8323.147.130.080.21
Upgrade
Repurchase of Common Stock
---0.15--
Upgrade
Other Financing Activities
--0.5521.64--0.44
Upgrade
Financing Cash Flow
36.742.3238.6121.219.39
Upgrade
Foreign Exchange Rate Adjustments
0.050.02---
Upgrade
Net Cash Flow
-0.235.195.89-1.63-5.07
Upgrade
Free Cash Flow
-36.97-37.16-32.76-22.83-24.46
Upgrade
Free Cash Flow Per Share
-2.41-3.04-6.48-72.26-1.60
Upgrade
Levered Free Cash Flow
-21.67-23.7-16.94-20.49-12.51
Upgrade
Unlevered Free Cash Flow
-20.96-23.42-16.28-18.24-11.96
Upgrade
Change in Working Capital
-3.453.96-0.06-0.150.87
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.